Logo-ipp
Submitted: 29 Oct 2021
Accepted: 10 Dec 2021
ePublished: 25 Dec 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Immunopathol Persa. 2022;8(2): e29325.
doi: 10.34172/ipp.2022.29325
  Abstract View: 387
  PDF Download: 428

Original

The soluble major histocompatibility complex class I chain-related gene A (sMICA) as an early biomarker for diagnosing acute myocardial infarction

Kambiz Masoumi 1 ORCID logo, Ali Khavanin 1* ORCID logo, Meisam Moezzi 1 ORCID logo, Habib Heybar 2 ORCID logo, Nastaran Ranjbari 3 ORCID logo, Nader Masoumi 1 ORCID logo, Mehdi Mokhtari 4 ORCID logo

1 Department of Emergency Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Department of Cardiology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Department of Pathology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4 Department of Epidemiology, Iran University of Medical Sciences, Tehran, Iran
*Corresponding Author: Correspondence to Ali Khavanin, Email: , Email: khavanin-a@ajums.ac.ir

Abstract

Introduction: It is necessary to identify tests that have high diagnostic power in the early hours of acute myocardial infarction.

Objectives: In this study, we investigated the major histocompatibility complex class I chain-related molecule A (MICA) in the serum of patients with myocardial infarction (MI).

Patients and Methods: In this study, 65 patients with MI were studied. Creatine phosphokinase-MB (CPK-MB), troponin I, and MICA biomarkers were measured at different times after hospitalization (0, 3, 6, 9, 12 and, 24 hours). These biomarkers were evaluated at different times after chest pain (0 to 3, 3 to 6, and more than 6 hours).

Results: Serum MICA biomarker increased significantly from admission to the hospital until 3 hours. Later on, it decreased until 24 hours. However, CPK-MB biomarkers as well as troponin I, change from admission up to 24 hours. Regarding diagnostic power, it was found that the diagnostic power of MICA is high in the early hours which indicates the high diagnostic power of the test.

Conclusion: The diagnostic value of MICA is significant in the early hours after MI. Therefore, due to the high accuracy of MICA in diagnosing MI, it should be used as a diagnostic test along with other tests to confirm MI in the early hours.


Citation: Masoumi K, Khavanin A, Moezzi M, Heybar H, Ranjbari N, Masoumi N, Mokhtari M. The soluble major histocompatibility complex class I chainrelated gene A (sMICA) as an early biomarker for diagnosing acute myocardial infarction. Immunopathol Persa. 2022;8(2):e29325. DOI:10.34172/ ipp.2022.29325.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 388

Your browser does not support the canvas element.


PDF Download: 428

Your browser does not support the canvas element.